
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2022 | 0 | 6.535.672 | 0 | 1 | ||
| 2021 | 0 | 2.281.840 | 0 | 1 | ||
| 2020 | 0 | 1.058.000 | 0 | 1 | ||
Total number of partners: 51
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 51
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2022-09-01 | Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival | EChiLiBRiST | participant | 6.535.672 | 12 |
| 2021-01-01 | Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials | SISAQOL-IMI | participant | 2.281.840 | 33 |
| 2020-01-01 | Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs | InterTAU | participant | 1.058.000 | 9 |